Intercept Pharmaceuticals
ICPT
$19.00
Share price
0.00%
Change (1 day)
-7.90%
Change (1 year)
Categories
Intercept Pharmaceuticals (ICPT) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $0.32 B
According to Intercept Pharmaceuticals 's latest financial reports the company's total liabilities are $0.32 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Intercept Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.46 B | -35.21% |
| 2021-12-31 | $0.71 B | -4.86% |
| 2020-12-31 | $0.74 B | 6.26% |
| 2019-12-31 | $0.70 B | 43.53% |
| 2018-12-31 | $0.49 B | 4.72% |
| 2017-12-31 | $0.46 B | 10.28% |
| 2016-12-31 | $0.42 B | 691.51% |
| 2015-12-31 | $53.6 M | 130.5% |
| 2014-12-31 | $23.25 M | -65.75% |
| 2013-12-31 | $67.91 M | 46.78% |
| 2012-12-31 | $46.26 M | 110.02% |
| 2011-12-31 | $22.03 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $53.14 B | 16,438.99% | 🇺🇸 USA |
 Gilead Sciences GILD | $39.37 B | 12,154.56% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 20,339.01% | 🇺🇸 USA |
 MediciNova MNOV | $3.89 M | -98.79% | 🇺🇸 USA |